cabergoline has been researched along with Day Blindness in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Canturk, S; Dogansen, S; Hacisahinogullari, H; Yarman, S | 1 |
| Ishihara, E; Ogawa, K; Ozawa, H; Saito, S; Sasao, R; Toda, M; Yoshida, K | 1 |
| Abe, T; Ebashi, R; Koguchi, M; Masuoka, J; Nakahara, Y; Ogata, A; Shimokawa, S | 1 |
| Cuevas, JL; Fernández, V; González, O; Rojas, D; Torche, E; Wohllk, N | 1 |
| Cámara Gómez, R; Del Olmo García, M; Merino Torres, JF; Querol Ripoll, R; Simal Julián, JA | 1 |
| Bronstein, MD; Espinosa, E; Glezer, A; Greenman, Y; Mendoza, V; Mercado, M; Popovic, V; Shimon, I; Sosa, E; Tirosh, A | 1 |
| Dhanjal, MK; Knight, M; Lambert, K; McCance, DR; Rees, K; Seed, PT; Williamson, C | 1 |
| Borson-Chazot, F; Delemer, B; Jacob, M; Jouanneau, E; Pugeat, M; Raverot, G; Vighetto, A | 1 |
| Astaf'eva, LI; Kadashev, BA; Kalinin, PL; Kutin, MA | 1 |
| Altomare, M; Colosimo, C; Corsello, SM; Lovicu, RM; Migneco, MG; Rota, CA; Ubertini, G | 1 |
| Brabant, G; Bremer, M; Cuarezma, JS; Karstens, JH; Lenarz, T; Samii, M; Schöfl, C; Schöfl-Siegert, B; von zur Mühlen, A | 1 |
| Ball, SG; Connolly, V; James, RA; Kane, P; Kelly, WF; Kendall-Taylor, P; Mathias, D; Perros, P; Quinton, R; Sibal, L; Vaidya, B | 1 |
| Benbassat, C; Hadani, M; Shimon, I | 1 |
| Allen, K; Byrne, JV; Cudlip, S; De Silva, SR; Soni, A; Wass, JA | 1 |
| Agostini, S; Billeci, D; Conte, N; De Menis, E; Marton, E; Tramontin, P; Visentin, A | 1 |
15 other study(ies) available for cabergoline and Day Blindness
| Article | Year |
|---|---|
Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Female; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Vision Disorders; Visual Fields | 2022 |
Endonasal Chiasmapexy Using Autologous Cartilage/Bone for Empty Sella Syndrome After Cabergoline Therapy for Prolactinoma.
Topics: Adult; Bone Transplantation; Cabergoline; Cartilage; Dopamine Agonists; Empty Sella Syndrome; Humans; Male; Natural Orifice Endoscopic Surgery; Prolactinoma; Transplantation, Autologous; Vision Disorders | 2019 |
Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report.
Topics: Adult; Anticonvulsants; Cabergoline; Dopamine Agonists; Fatigue; Frontal Lobe; Humans; Hydrocortisone; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Status Epilepticus; Thyroxine; Treatment Outcome; Vision Disorders | 2019 |
[Visual outcome in patients with macroprolactinoma treated with dopamine agonists].
Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prolactinoma; Retrospective Studies; Vision Disorders; Visual Acuity; Visual Fields; Young Adult | 2013 |
[Pituitary apoplexy in a pregnant woman with cystic microprolactinoma].
Topics: Adult; Bromocriptine; Cabergoline; Combined Modality Therapy; Contraindications; Dopamine Agonists; Drug Substitution; Ergolines; Female; Headache; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypophysectomy; Infant, Newborn; Male; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactinoma; Thyroxine; Vision Disorders | 2015 |
Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.
Topics: Adolescent; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Child; Ergolines; Female; Galactorrhea; Headache; Hormone Antagonists; Humans; Male; Middle Aged; Neurosurgical Procedures; Pituitary Neoplasms; Prolactinoma; Sexual Dysfunction, Physiological; Treatment Outcome; Tumor Burden; Vision Disorders; Young Adult | 2016 |
Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
Topics: Adenoma; Adult; Amenorrhea; Antineoplastic Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cesarean Section; Dopamine Agonists; Ergolines; Female; Galactorrhea; Humans; Incidence; Pituitary Neoplasms; Pre-Eclampsia; Preconception Care; Pregnancy; Pregnancy Complications, Neoplastic; Premature Birth; Prolactinoma; Prospective Studies; Stillbirth; United Kingdom; Vision Disorders; Young Adult | 2017 |
Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Male; Middle Aged; Optic Chiasm; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Vision Disorders; Visual Fields; Young Adult | 2009 |
[Complications of treatment of prolactinoma by dopamine agonists].
Topics: Adolescent; Adult; Cabergoline; Cerebrospinal Fluid Rhinorrhea; Dopamine Agonists; Ergolines; Humans; Intracranial Hemorrhages; Male; Middle Aged; Neurosurgical Procedures; Pituitary Neoplasms; Prolactinoma; Radiography; Treatment Outcome; Vision Disorders; Young Adult | 2011 |
Giant prolactinomas in men: efficacy of cabergoline treatment.
Topics: Adrenal Glands; Adult; Aged; Antineoplastic Agents; Cabergoline; Erectile Dysfunction; Ergolines; Humans; Hypothyroidism; Libido; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Vision Disorders | 2003 |
Falsely low serum prolactin in two cases of invasive macroprolactinoma.
Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; False Negative Reactions; Headache; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Function Tests; Pituitary Neoplasms; Prolactin; Prolactinoma; Skull Base Neoplasms; Vision Disorders | 2002 |
Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Cabergoline; Combined Modality Therapy; Decompression, Surgical; Ergolines; Female; Humans; Hypopituitarism; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Apoplexy; Pituitary Gland; Pituitary Neoplasms; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vision Disorders | 2004 |
Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men.
Topics: Adult; Antineoplastic Agents; Cabergoline; Ergolines; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Time Factors; Treatment Outcome; Vision Disorders; Visual Fields | 2007 |
A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy.
Topics: Angiography, Digital Subtraction; Antineoplastic Agents; Balloon Occlusion; Cabergoline; Carotid Artery, Internal; Dopamine Agonists; Ergolines; Headache; Humans; Intracranial Aneurysm; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Ophthalmoplegia; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma; Treatment Outcome; Vision Disorders | 2008 |
Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases.
Topics: Acromegaly; Adenoma; Adolescent; Amenorrhea; Bromocriptine; Cabergoline; Child; Ergolines; Female; Headache; Human Growth Hormone; Humans; Male; Neoplasm Recurrence, Local; Octreotide; Pituitary Neoplasms; Prolactinoma; Puberty, Delayed; Radiotherapy; Treatment Outcome; Vision Disorders; Visual Fields | 2001 |